Roffman Miller Associates Inc. PA Has $2.28 Million Stock Position in Colgate-Palmolive Company (NYSE:CL)

Roffman Miller Associates Inc. PA lifted its holdings in Colgate-Palmolive Company (NYSE:CL - Free Report) by 31.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,359 shares of the company's stock after buying an additional 5,845 shares during the period. Roffman Miller Associates Inc. PA's holdings in Colgate-Palmolive were worth $2,282,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Westend Capital Management LLC lifted its position in Colgate-Palmolive by 111.1% in the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after buying an additional 140 shares in the last quarter. Vermillion Wealth Management Inc. purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth $31,000. Briaud Financial Planning Inc acquired a new stake in Colgate-Palmolive during the fourth quarter valued at $32,000. Wintrust Investments LLC acquired a new stake in Colgate-Palmolive during the fourth quarter valued at $33,000. Finally, Bernard Wealth Management Corp. acquired a new position in Colgate-Palmolive in the fourth quarter worth approximately $33,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

Shares of NYSE CL traded up $0.60 during trading hours on Monday, reaching $93.38. The stock had a trading volume of 5,794,090 shares, compared to its average volume of 4,816,411. Colgate-Palmolive Company has a twelve month low of $85.32 and a twelve month high of $109.30. The company has a debt-to-equity ratio of 8.96, a current ratio of 0.85 and a quick ratio of 0.54. The business's fifty day moving average is $90.61 and its two-hundred day moving average is $90.52. The company has a market cap of $75.68 billion, a price-to-earnings ratio of 26.38, a PEG ratio of 4.93 and a beta of 0.37.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The company had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. The business's revenue was down 3.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.86 EPS. As a group, research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be paid a $0.52 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.08 annualized dividend and a dividend yield of 2.23%. Colgate-Palmolive's dividend payout ratio is currently 58.76%.

Colgate-Palmolive announced that its Board of Directors has approved a stock buyback plan on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 6.8% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's board of directors believes its shares are undervalued.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research note on Monday, April 28th. Barclays reduced their price target on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research report on Friday, April 11th. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Citigroup boosted their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a report on Monday, April 28th. Finally, Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research report on Wednesday, April 2nd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive has an average rating of "Hold" and an average price target of $101.69.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.